STRONGBRIDGE BIOPHARMA plc (NASDAQ:SBBP) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
On January 9, 2020, Strongbridge Biopharma plc (the “Company”) issued a press release announcing preliminary fourth quarter and full-year 2019 financial results and providing an update on corporate priorities. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 is being furnished to the Commission and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document to the Securities Act of 1933, as amended (the “Securities Act”), except as expressly set forth by specific reference in such filing. The information set forth herein will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.
Item 7.01Regulation FD.
The response to Item 2.02 is incorporated herein by reference to this Item 7.01.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits
